Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allphamed PHARBIL Arzneimittel is a specialized contract development and manufacturing organization (CDMO) based in Göttingen, Germany, and a key subsidiary of the NextPharma group. The facility serves as a center of excellence for the production of non-sterile liquid and semi-solid dosage forms, including syrups, oral drops, gels, and ointments. It provides comprehensive services ranging from pharmaceutical formulation development and clinical trial supply to large-scale commercial manufacturing and analytical testing. The site is GMP-certified and supports a global client base within the pharmaceutical and healthcare industries. By leveraging advanced filling and packaging technologies, Allphamed PHARBIL plays a critical role in the supply chain for international pharmaceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allphamed PHARBIL Arzneimittel.